Paul Isaac Buys 20,000 Shares of Stereotaxis (NYSEAMERICAN:STXS) Stock

Stereotaxis Inc. (NYSEAMERICAN:STXS) Director Paul Isaac purchased 20,000 shares of the stock in a transaction dated Friday, November 14th. The shares were bought at an average price of $2.24 per share, for a total transaction of $44,800.00. Following the completion of the acquisition, the director owned 2,786,557 shares in the company, valued at $6,241,887.68. This represents a 0.72% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Stereotaxis Trading Down 2.2%

STXS opened at $2.24 on Thursday. The stock has a fifty day moving average price of $2.89 and a 200 day moving average price of $2.54. Stereotaxis Inc. has a 1 year low of $1.54 and a 1 year high of $3.59. The stock has a market cap of $204.00 million, a price-to-earnings ratio of -7.72 and a beta of 1.65.

Analysts Set New Price Targets

STXS has been the topic of a number of research reports. Roth Capital restated a “buy” rating and issued a $4.00 price objective on shares of Stereotaxis in a report on Wednesday, November 12th. UBS Group set a $4.00 price target on shares of Stereotaxis in a report on Wednesday, November 5th. One analyst has rated the stock with a Buy rating, According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $4.00.

Institutional Investors Weigh In On Stereotaxis

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Lagoda Investment Management L.P. increased its stake in shares of Stereotaxis by 0.4% in the third quarter. Lagoda Investment Management L.P. now owns 4,707,400 shares of the company’s stock worth $14,640,000 after purchasing an additional 19,500 shares during the period. Vanguard Group Inc. grew its holdings in Stereotaxis by 4.2% in the 3rd quarter. Vanguard Group Inc. now owns 3,441,091 shares of the company’s stock valued at $10,702,000 after buying an additional 138,482 shares during the last quarter. Essex Investment Management Co. LLC increased its position in Stereotaxis by 3.5% in the 3rd quarter. Essex Investment Management Co. LLC now owns 1,598,114 shares of the company’s stock worth $4,970,000 after buying an additional 53,358 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Stereotaxis by 0.9% during the second quarter. Geode Capital Management LLC now owns 1,478,201 shares of the company’s stock worth $3,135,000 after buying an additional 13,891 shares during the last quarter. Finally, Warberg Asset Management LLC boosted its position in shares of Stereotaxis by 260.1% in the second quarter. Warberg Asset Management LLC now owns 1,201,500 shares of the company’s stock valued at $2,547,000 after acquiring an additional 867,878 shares during the period. 45.35% of the stock is owned by institutional investors and hedge funds.

Stereotaxis Company Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.